WO2023041979 - METHODS AND COMPOSITIONS FOR TREATING CANCER AND ENHANCING IMMUNE CHECKPOINT INHIBITOR EFFICACY

National phase entry:
Publication Number WO/2023/041979
Publication Date 23.03.2023
International Application No. PCT/IB2022/000515
International Filing Date 14.09.2022
Title **
[English] METHODS AND COMPOSITIONS FOR TREATING CANCER AND ENHANCING IMMUNE CHECKPOINT INHIBITOR EFFICACY
[French] MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DU CANCER ET L'AMÉLIORATION DE L'EFFICACITÉ D'UN INHIBITEUR DE POINT DE CONTRÔLE IMMUNITAIRE
Applicants **
GNUBIOTICS SCIENCES SA
ADESOKAN, Adeyemi
WYSS, Romain
MIAO, Yong
Inventors
ADESOKAN, Adeyemi
WYSS, Romain
MIAO, Yong
Priority Data
63/244,227   14.09.2021   US
63/273,105   28.10.2021   US
63/296,431   04.01.2022   US
63/308,011   08.02.2022   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting4763
EPO Filing, Examination, Granting42453
Japan Filing, Examination, Granting3510
South Korea Filing, Examination, Granting4934
USA Filing, Examination, Granting18690
MasterCard Visa
Total: 74,350

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] Provided herein are methods and compositions for treating a tumor or increasing the anti-cancer effectiveness of an immune checkpoint inhibitor using glycopeptide containing compositions.[French] L'invention concerne des méthodes et des compositions permettant de traiter une tumeur ou d'augmenter l'efficacité anticancéreuse d'un inhibiteur de point de contrôle immunitaire à l'aide de compositions contenant des glycopeptides.